Andy Chen's Stock Ratings

Wolfe Research Analyst

Andy Chen is an analyst at Wolfe Research. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 01/03/2025

Overall Average Return

-6.42%

Smart Score

43.5%

Overall Average Return Percentile

25th

Number of Ratings

29
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

What Analysts Are Saying About Celldex Therapeutics Stock
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
This Airbnb Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
The Latest Analyst Ratings For Kymera Therapeutics
Analyst Expectations For Celldex Therapeutics's Future
Co. Says Geoprobe Drilling Found 'Consistent' Lithium, Boron Concentrations
Source: Streetwise Reports 10/15/2024
The Analyst Landscape: 7 Takes On Kymera Therapeutics
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved